FDA Inspection 1121127 — HCSC-Blood Center

HCSC-Blood Center — FEI 2573135

The FDA completed an inspection of HCSC-Blood Center on February 21, 2020 in Bethlehem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 21, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Bethlehem, PA (United States)